Venetoclax combinations in untreated CLL and the Clinical Significance of Clonal Monocytosis

In this week's episode, Blood editor Dr. Laura Michaelis interviews Dr. Moritz Fürstenau of University Hospital Cologne and Dr. William Dunn of the University of Cambridge on their latest articles published in Blood on CLL and clonal monocytosis. Dr. Fürstenau discusses "Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial" highlighting greater improvements in patient-reported quality of life.  Dr. Dunn discusses "The prevalence and clinical significance of clonal monocytosis" describing how using sex-specific monocyte thresholds and excluding isolated DNMT3A mutations refines the association between CMUS and MN.

Creators and Guests

LM

Host

Laura Michaelis

What is Blood Podcast?

Stay up to date on the latest research and reviews for both clinical and basic hematology with Blood podcast, published weekly in conjunction with each issue of Blood. Additionally, Blood review series podcasts feature in depth discussion with authors of recently published review articles. Subscribe and never miss a new episode.